Defense & Aerospace

Benefiting from rising global defense spending

Next Rebalance: 2026-07-01
Loading chart...
Portfolio Metrics
Total Return
--
Sharpe Ratio
--
Max Drawdown
--
Risk Level
--
Current Holdings
Loading holdings...
Rebalance History

Apr 1, 2026

0 9 0
AVAV, BA, DE +6 more

New Positions

KTOS 0.0% 25.0%
Kratos is experiencing a major inflection point driven by significant, newly announced contract wins. The company's role... Kratos is experiencing a major inflection point driven by significant, newly announced contract wins. The company's role as the prime contractor on the $1.45B MACH-TB 2.0 hypersonic program is a transformative, near-term catalyst. [🔗](https://cognitmarket.com/article/1d437807/rocket-lab-just-won-its-biggest-contract-ever) This, coupled with smaller but consistent awards and strong geopolitical tailwinds for its drone and hypersonic technologies, suggests accelerating revenue and margin expansion. [🔗](https://cognitmarket.com/article/1f182f24/1-defense-stock-cathie-wood-is-buying-now-as-the-u) While valuation is high, the powerful combination of a record backlog, major program de-risking, and strong financial momentum is not yet fully priced in.
RKLB 0.0% 25.0%
Positive near-term catalysts include the Mynaric acquisition closing in April, which secures a critical supplier for lar... Positive near-term catalysts include the Mynaric acquisition closing in April, which secures a critical supplier for large government contracts, and the first of 20 HASTE hypersonic test launches expected within months. [🔗](https://cognitmarket.com/article/095af7f2/rocket-lab-receives-approval-to-acquire-mynaric-in) These events demonstrate strong execution and backlog conversion. However, sentiment is tempered by a significant $1 billion equity distribution agreement, which creates a potential share price overhang and signals future capital needs. [🔗](https://cognitmarket.com/article/6de55018/rocket-lab-stock-falls-after-1-billion-equity-deal) Recent insider selling, though partially for tax purposes, and poor YTD stock performance also add caution. [🔗](https://cognitmarket.com/article/3e1d6eff/how-did-wsb-s-stock-picks-of-2026-perform-in-q1)
TER 0.0% 25.0%
Teradyne's near-term outlook is strongly positive, driven by massive Q4 2025 earnings and revenue beats fueled by AI-rel... Teradyne's near-term outlook is strongly positive, driven by massive Q4 2025 earnings and revenue beats fueled by AI-related test demand. [🔗](https://cognitmarket.com/article/49214dae/teradyne-ter-q4-revenue-rises-44-to-1-083b-as-ai) Management provided robust Q1 2026 guidance, projecting continued growth across all segments, which has led to numerous upward analyst revisions. [🔗](https://cognitmarket.com/article/7d5f0668/aletheia-sees-teradyne-stock-benefiting-from) The launch of new test platforms for silicon photonics (Photon 100) and complex PCBs (Omnyx) directly addresses the increasing complexity of AI hardware, creating clear catalysts. [🔗](https://cognitmarket.com/article/66f11e1b/teradyne-launches-automated-test-platform-for) While valuation is a concern and some insiders (ARK) are selling, the overwhelming momentum from AI infrastructure spending should drive outperformance. [🔗](https://cognitmarket.com/article/2bcd9c18/teradynes-5g-fr2-open-ran-push-faces-rich-question)
GE 0.0% 15.0%
AVAV 0.0% 2.0%
Recent earnings missed expectations, guidance was lowered, and the company recorded a significant $151.3M goodwill impai... Recent earnings missed expectations, guidance was lowered, and the company recorded a significant $151.3M goodwill impairment charge due to a stop-work order on the BADGER program [🔗](https://cognitmarket.com/article/735a8596/aerovironment-avav-reports-408m-fq3-2026-revenue). The recompete of the $1.4B SCAR program, AVAV's largest, creates substantial uncertainty and risk to its $1.1B backlog [🔗](https://cognitmarket.com/article/471ebcc2/raymond-james-downgrades-aerovironment-stock-on). While new contract wins ($135M) and product announcements (LOCUST X3) are positive, they are overshadowed by the magnitude of the SCAR program risk and recent operational issues [🔗](https://cognitmarket.com/article/5a78c215/aerovironment-unveils-locust-x3-laser-weapon). Executive turnover, including the COO and CFO, adds to near-term uncertainty [🔗](https://cognitmarket.com/article/f47e886c/aerovironment-cfo-mcdonnell-sells-88921-in-shares).
BA 0.0% 2.0%